Co-chair

David Cameron is Professor of Oncology and Director of Cancer Services at NHS Lothian.
He has worked extensively in cancer research, and has a particular interest in the use of routine clinical data to improve patient care through his current role as director of the Scottish Government funded Innovative Health Care Delivery Programme (IHDP).

Co-chair

Iwona Lugowska is the Head of Early Phase Clinical Trials Unit at Maria Sklodowska Curie National Research Institute of Oncology.
Her research interests include precision oncology and decision support systems for cancer patients. She also has a strong interest in leadership development, having been a member of the first cohort of the EORTC Early Career Programme in 2018/9.

Massimo Di Maio is Professor of Medical Oncology at Department of Oncology, University of Turin.
He has deep experience of cancer research, with particular interest in the methodology of clinical trials and in the study of patient reported outcomes (PROs), both in clinical research and in clinical practice.

Sue Cheeseman is a practicing oncologist and active researcher in oncology Real World Evidence (RWE).
She is a pivotal figure in the REAL-Oncology alliance at Leeds Teaching Hospital, and she has published extensively on real world research in multiple tumor types.

James Anderson has worked extensively in healthcare, both in the NHS and the private sector.
In recent years he has supported life sciences companies in innovative uses of real world evidence in oncology, such as external comparators. He has a particular interest in people development, having previously run training programmes in the public and private sector, and is a qualified and accredited executive coach.

Rachel Giles is an experienced Associate Professor and professional patient advocate with decades of experience in the hospital & health care industry. She is currently the president of VHL Europa, an organisation dedicated to improving the lives of individuals affected by Von Hippel-Lindau (VHL) disease.

Asieh Golozar is a physician-epidemiologist and biostatistician with over 20 years of experience in health services research and real-world evidence generation. She is currently the Director of Clinical Research at the OHDSI Center at Northeastern University and an adjunct faculty member at Johns Hopkins School of Public Health.

Will Sopwith is an experienced Real World Evidence researcher, epidemiologist and writer. He has supported DIGICORE training programmes since their inception and also heads up IQVIA’s Oncology Evidence Network in the UK.

James Brash is a Senior Healthcare Data Scientist at IQVIA, where he is an expert leader, delivering Real World Evidence studies using OMOP standards.

Mieke Van Hemelrijk is a Professor of Cancer Epidemiology at King's College London, where she leads the Translational Oncology and Urology Research (TOUR) team. Her research focuses on improving outcomes and experiences for cancer patients, particularly in urological cancers, and she has published extensively in this field.